Skip to main content

Table 9 Adjusted Relative Risk of VTE due to Cisplatin based Chemotherapy

From: Incidence of Venous Thromboembolism in cancer patients treated with Cisplatin based chemotherapy — a cohort study

 

β coefficient

SE (β)

Relative Risk

95% CI for RR

Cisplatin based chemotherapy

1.2

0.37

3.32

1.6–6.8

  1. adjusted for ECOG, Khorana risk score, GCSF, presence of CVC and gender-log likelihood =471.38
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us